Qualitek Labs Ltd (QLL) is currently trading at 554.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Qualitek Labs is a testing, inspection and certification (TIC) company providing laboratory and on‑site services across automotive, defence, pharmaceuticals, medical devices, minerals, food, water, environment and electronics, operating a pan‑India network of 10 owned labs and 6 PPP government labs with more than 1,200 employees and over five million tests annually. In FY26 Qualitek Labs reported consolidated revenue of INR 124.5 crore, a 77% year‑on‑year increase, with EBITDA of INR 29.3 crore and PAT of INR 14.6 crore; these results reflect margin improvement, operational leverage and consolidation benefits after acquisitions, marking the company’s strongest financial year since listing. The company has actively deployed capital with INR 51.3 crore spent in FY26 and a planned INR 63 crore for FY27 to expand capacity, add specialised capabilities such as EMI/EMC and VOC testing, and pursue USFDA‑grade pharma accreditation, positioning Qualitek Labs to capture higher‑value testing mandates. Qualitek Labs leverages strategic government and international relationships, operating six PPP labs and offering homologation and regulatory consultancy to export clients, while NABL accreditations and multi‑segment services create differentiation and provide access to institutional and OEM customers in regulated domains.

Over the past 52 weeks, Qualitek Labs Ltd has traded between a low of ₹258.55 and a high of ₹650.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Qualitek Labs Ltd has a market capitalization of approximately 640.86. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Qualitek Labs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 46.57 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 640.86 Cr, Qualitek Labs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Qualitek Labs Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Qualitek Labs Ltd is 46.57. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The board meeting is scheduled for September 22, 2026, to consider proposals for raising funds.